Glass House Brands recently told MJBizDaily that the age of legitimate interstate commerce is at hand. The company cited its new DEA export registration as a key milestone. It also noted a first shipment of flower to Europe.
This move signals a shift in how major cultivators view federal regulations.
The Department of Justice moved state-licensed medical cannabis to Schedule 3 in April. In June, the U.S. Drug Enforcement Administration opened a hearing on broader rescheduling. These actions create a pathway for national distribution.
California, Oregon, and Washington already have interstate commerce statutes on the books. They are waiting for the federal green light to activate these laws.
Operators are now treating interstate commerce as a manufacturing capability. This capability takes years to build and does not appear the moment the law changes.
Companies are building this infrastructure now inside the current patchwork. They do this while everyone else waits for permission to trade across borders.
Cannabis consumers notice inconsistency constantly across flower, vapes, edibles, and concentrates. A brand they loved in California was unrecognizable in Maryland. The same logo and packaging often hide completely different products.
This inconsistency is the clearest evidence that cannabis has not learned to manufacture like a real sector. The structural reason is that product cannot legally cross state lines.
Every state market is its own island under current rules. An operator in seven states runs seven separate supply chains. They source seven batches of biomass and hand them to seven teams.
They hope the output lands in the same place. In this way, the same brand is often seven different products wearing one label. This lack of standardization frustrates loyal customers who expect uniform quality.
Other industries solved this exact problem generations ago. A regional bakery chain runs 20 locations across five states. It hands you the same loaf at every one.
That consistency comes from ingredients refined to a known specification. Repeatable inputs make repeatable outputs. The wine industry also uses blending to deliver a consistent experience on top of inconsistent raw materials.
The better model splits manufacturing into two distinct disciplines. Extraction purifies biomass into two standardized ingredients. These are a high-purity THC isolate and a high-terpene extract.
Each is made to a testable specification. Formulation then recombines them just in time. It follows a documented recipe with defined targets for potency, viscosity, color, and terpene profile.
Every batch is produced to a spec you can measure. This unlocks a national brand under current law. You source biomass separately in each state as the rules require.
You still land on the same finished product. This happens as long as you purify that local biomass into ingredients that hit the same spec. Consistency no longer depends on where the plant grew or who ran the lab that day.
The old model relied on an extract artist to keep the process in his head. You cannot clone that specialist across seven states. A process living in one person’s intuition will never be repeatable.
This is your own version of interstate commerce, and it is legal today.
Expert Warning On Outdated Testing Dr Georges Petitjean has warned that workplace drug testing has failed to keep pace with…
Event Details Shore House Canna, an adult-use dispensary in West Cape May, New Jersey, will host its 3rd Annual Fall…
Sabalenka Stops Play Over Cannabis Smell Top seed Aryna Sabalenka briefly halted her US Open third-round match against Kamilla Rakhimova…
CBDD Signs Definitive Agreement to Acquire BioCannabis CBD of Denver, Inc. (OTCID: CBDD) announced on September 15, 2026 that it…
Seventh Annual New Jersey Cannabis Convention Set NECANN brings the New Jersey Cannabis Convention back to the Atlantic City Convention…
The Violation Vermont Lt. Gov. John Rodgers plans to pay a reduced fine to settle a case involving an unlicensed…